Comparison of Khandu chakka leaves powder with Diclofenac Sodium tablet in the management of Pai
Phase 3
- Conditions
- Health Condition 1: G892- Chronic pain, not elsewhere classified
- Registration Number
- CTRI/2021/04/032597
- Lead Sponsor
- Datte Meghe Institute of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Musculo-Skeletal pain, Joint Pain, Back Pain and Cervical Pain
Exclusion Criteria
Abdominal Pain, Traumatic Pain, Pain due to life threatening conditions. Intolerable pain, Patients having abnormal haematological and biochemistry parameters.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method management of painTimepoint: Pain assessment after every 3rd day
- Secondary Outcome Measures
Name Time Method improvement in the painTimepoint: 15th day